Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) were associated with improved left ventricular diastolic function and New ...
BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced initial dosing in a Phase 1 trial of EDG-7500.
Please provide your email address to receive an email when new articles are posted on . Few therapies have improved symptoms for patients with nonobstructive hypertrophic cardiomyopathy. In a small ...
Hypertension is believed to be the single greatest factor influencing the development of heart failure, particularly heart failure with preserved ejection fraction, also known as diastolic heart ...
The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...
Medically reviewed by Jeffrey S. Lander, MDFact checked by Nick BlackmerMedically reviewed by Jeffrey S. Lander, MDFact checked by Nick Blackmer Diastolic dysfunction refers to a cardiac condition ...
COLUMBUS, Ohio (Ivanhoe Newswire) - Diastolic heart failure happens when the left ventricle, or the pumping chamber of a person’s heart becomes stiff, and blood can’t flow from the heart into the ...
Heart failure with normal systolic function has been equated to diastolic heart failure (DHF). DHF appears to be quite common in the elderly, especially in elderly women with hypertension. Recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results